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The tumor suppressor p53 is activated by stress
and leads to cellular outcomes such as apoptosis
and cell-cycle arrest. Its activation must be highly
sensitive to ensure that cells react appropriately to
damage. However, proliferating cells often encounter
transient damage during normal growth, where cell-
cycle arrest or apoptosis may be unfavorable. How
does the p53 pathway achieve the right balance
between high sensitivity and tolerance to intrinsic
damage? Using quantitative time-lapse microscopy
of individual human cells, we found that proliferating
cells show spontaneous pulses of p53, which are
triggered by an excitable mechanism during cell-
cycle phases associated with intrinsic DNA damage.
However, in the absence of sustained damage, post-
translational modifications keep p53 inactive, pre-
venting it from inducing p21 expression and cell-
cycle arrest. Our approach of quantifying basal
dynamics in individual cells can nowbe used to study
how other pathways in human cells achieve sensi-
tivity in noisy environments.INTRODUCTION
A multicellular organism must keep a delicate balance: on one
hand, cells must preserve the integrity of their genome and other
essential structures to prevent aberrant cell behavior, which
could lead to failure of tissue function or the formation of cancer.
To this end, complex sensing mechanisms detect cellular
damage with high sensitivity and activate the appropriate
response such as cell-cycle arrest or apoptosis (Bakkenist and
Kastan, 2004). On the other hand, cells are constantly subjected
to intrinsic stress caused by normal physiological processes
such as growth and division. Halting the cell cycle, or killing
the cell, in response to each of these transient events might be
problematic. How do signaling pathways, and specifically
stress-response pathways, achieve the right balance between
high sensitivity and tolerance to transient spontaneous damage
during normal growth?A central protein in the mammalian stress response is the
tumor suppressor p53 (Vogelstein et al., 2000; Vousden and
Lane, 2007). p53 is activated by upstream kinases that respond
to different forms of cellular stress (Figure 1A). For example, DNA
double-strand breaks (DSBs) lead to activation of the kinases
ataxia telengiectesia mutated (ATM) and checkpoint kinase 2
(Chk2). This activation mechanism is highly sensitive; one or
two breaks in the human genome were found to be sufficient
for partial induction of ATM, and full ATM activation is achieved
by less than 20 DSBs (Bakkenist and Kastan, 2003; Huang et al.,
1996). Active ATM and Chk2 phosphorylate p53 (Figure 1A),
leading to its stabilization and accumulation in the nucleus.
p53 then acts as a transcription factor for numerous target genes
involved in stress-response pathways ranging from DNA repair
to apoptosis (Riley et al., 2008). In addition, p53 regulates the
expression of proteins that modulate its own activation and
stability, forming multiple positive and negative feedback loops
(Harris and Levine, 2005). The most prominent feedback loop
is between p53 and the E3 ubiquitin ligase mouse/human double
minute 2 (Mdm2/Hdm2) (Kruse and Gu, 2009); p53 positively
activates Mdm2 transcription, and Mdm2 negatively regulates
p53 stability by targeting it for proteasomal degradation (Wu
et al., 1993). p53, ATM, and Chk2 form additional negative feed-
back loops that are mediated by p53 dependent expression of
the phosphatase Wip1 (Batchelor et al., 2008; Fiscella et al.,
1997; Lu et al., 2007; Shreeram et al., 2006) (Figure 1A).
Posttranslational modifications of p53 are important modula-
tors of its function and stability (Bode and Dong, 2004).
Currently, modifications have been detected on at least 30
different sites on the p53 protein. The function of several of these
modifications is well understood. For example, Mdm2-mediated
ubiquitination of p53’s C-terminal lysine residues targets p53 to
degradation. For others, it is less clear what role they play in
regulating p53. It has been proposed that the specific combina-
tion of modifications on p53 may provide selectivity toward
a particular cellular response. However, it is still unclear which
of the enormous number of possible p53 modification patterns
occur in living cells in different conditions and what their specific
function is (Toledo and Wahl, 2006).
In addition, even though the p53 network and the DNA-
damage response are among the most investigated signaling
pathways in mammalian cells, most studies focus on the induc-
tion of p53 after stress. Very little is known about the basal
dynamics of p53 in proliferating cells. In most studies, the basalCell 142, 89–100, July 9, 2010 ª2010 Elsevier Inc. 89
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Figure 1. p53 Levels Vary in Populations of Nonstressed Cells
(A) Diagram showing key species of the p53 signaling network.
(B and C) p53 levels in nonstressed conditions (B) or after DNA damage induced by neocarzinostatin (NCS, 400 ng/ml) (C) as measured by fluorescence micros-
copy.
(D and E) Distributions of p53 levels in HCT116 (D) andMCF10A (E) cells in nonstressed conditions and after damage (400 ng/ml NCS, >23 104 cells per condition;
dashed line, normal distribution as a guideline). Most cells show low p53 levels in nonstressed conditions; the long right-sided tail represents cells with high p53
levels that overlap with those after DNA damage. The p53 signal was specific and themeasured distributions were independent of the p53 antibody used (Figures
S1G and S1H).
(F–F00) p53 levels in a section of normal human epidermis as measured by fluorescence microscopy. Cell nuclei were stained with DAPI (F0). Overlay of both
channels is shown in (F00).
See also Figure S1.level of p53 was simply determined by averaging over cell
populations prior to a specific treatment. On the basis of this
information, it has been suggested that p53 is kept at low levels
in basal conditions (Michael and Oren, 2003). However, it is
possible that by averaging over a population of cells, important
features of p53 dynamics are missed. For example, population
studies suggested that p53 levels show damped oscillations
after the induction of DSBs (Lev Bar-Or et al., 2000). Recent
studies using live single-cell imaging have shown that individual
human cells show varying numbers of undamped p53 pulses of
fixed amplitude and duration, which are independent of the
amount of damage (Batchelor et al., 2008; Geva-Zatorsky
et al., 2006; Lahav et al., 2004). The appearance of damped
oscillations in the population studies resulted from averaging
cells with different numbers of p53 pulses. Similarly, it is conceiv-
able that averaging p53 levels across a population of prolifer-
ating cells masks cell-cell variations such as asynchronous
events that can reveal the basal behavior of this pathway and
the way it responds to spontaneous damage during normal
growth.
Basal p53 dynamics during normal cell growth are of specific
interest when one considers that cells are constantly confronted
with various forms of stress. For example, DNA damage is90 Cell 142, 89–100, July 9, 2010 ª2010 Elsevier Inc.a common event: spontaneous hydrolysis leads to DNA depuri-
nation, reactive oxygen species induce base damage, and
collapsing replication forks leave the DNA backbone broken
(Branzei and Foiani, 2008; Sancar et al., 2004). It has been esti-
mated that the frequencies of DNA lesions range from ten DSBs
to as much as 104 bases damaged by oxidative stress per cell
per day. In addition, cells are confronted with other types of
insults, such as ribosomal or metabolic stress, which are also
known to activate p53 (Vousden and Lane, 2007; Vousden and
Prives, 2009).
In the present study, we focused on characterizing the basal
dynamics and function of p53 using quantitative time-series
measurements in individual cells. We found that proliferating
human cells show transient induction of p53 in nonstressed
conditions, giving the appearance of spontaneous pulses. These
pulses correlate with cell-cycle events associated with intrinsic
DNA damage and depend on a functional ATM/DNA-PK
pathway, suggesting that they represent the cellular response
to spontaneous double-strand breaks. We show that p53 is
activated by an excitable mechanism that leads to similar pulses
in nonstressed conditions as in response to severe damage
caused by irradiation or radiomimetic drugs. However, p53
pulses in nonstressed conditions do not lead to induction of
p21 or cell-cycle arrest, as sustained damage signaling is
required to change p53’s posttranslational modifications to an
active state. Our study demonstrates how the interplay between
the DNA damage-sensing pathway and the p53 pathway
enables cells to distinguish between transient low damage
during normal growth—which does not justify arrest or cell
death—and severe sustained damage that requires induction
of the full stress response.
RESULTS
Basal Dynamics of p53 in Nonstressed Conditions
To identify the basal level of p53 in individual cells, we first
measured p53 by immunofluorescence in HCT116 colon cancer
cells. Surprisingly, p53 levels were not uniform across the popu-
lation: most cells showed low levels of p53 as expected, but
several cells showed high p53 levels that were comparable to
those seen after the induction of DSBs by the radiomimetic
drug neocarzinostatin (NCS) (Shiloh et al., 1983) (Figures 1B
and 1C). We determined the distribution of basal p53 levels
in populations of additional cancerous (MCF7) and noncan-
cerous (MCF10A and RPE-hTERT) cells using automated image
analysis (Figures 1D and 1E and Figures S1A–S1H available
online). In all cell lines analyzed, the basal distribution of p53
showed a long right tail that overlapped with the distribution of
p53 in cells exposed to NCS.
To verify that high basal p53 levels are not restricted to cells
in culture, we measured p53 levels in thin sections of normal
human tissues using immunofluorescence. Similar to cultured
cells, we found a high variability in p53 levels in regenerating
tissues like epidermis or small intestine (Figures 1F–1F00 and
Figures S1I and S1J). In postmitotic tissues like breast epithelium
or cerebral cortex, a relatively small fraction of cells showed high
basal p53 levels (Figures S1K and S1L).
At least two scenarios can explain the observed variation in
p53 levels: individual cells have different constant steady-state
levels of p53, or p53 levels change dynamically in each cell. To
distinguish between these possibilities, we followed p53 levels
in individual cells over time with a fluorescently tagged p53
(Batchelor et al., 2008). In previous work, we showed that
fluorescently tagged p53 faithfully mimics the dynamics of
endogenous p53 in response to DNA damage and is functional
in activating its target genes and in inducing apoptosis (Batche-
lor et al., 2008; Lahav et al., 2004). We quantified the mean
nuclear fluorescent intensity in individual damaged cells and in
cells growing in nonstressed conditions and analyzed the result-
ing trajectories to extract statistical parameters describing p53
dynamics (Figures S2A and S2B and the Extended Experimental
Procedures). As previously reported, DNA damage induced
a series of uniform p53 pulses (Figures 2A and 2C) (Batchelor
et al., 2008; Geva-Zatorsky et al., 2006; Lahav et al., 2004).
Surprisingly, individual cells with no extrinsic damage showed
p53 pulses as well (Figures 2B and 2D and Movie S1). Almost
all cells show at least one p53 pulse in 24 hr, and about a third
of the cells show a series of three to five pulses (Figure 2G). Inter-
estingly, the amplitude and width of p53 pulses in nonstressed
conditions were similar to those after DNA damage induced by
NCS (Figures 2E and 2F) or g-irradiation (data not shown).However, as opposed to the synchronized pulses after damage,
the pulses in nonstressed conditions were asynchronous
(Figure 2H), explaining why they could not be detected in assays
that average p53 levels over a population of cells.
Our results show that in response to DNA damage, p53 does
not shift from a low steady state into a pulsing mode, but instead
shifts from asynchronous, spontaneous pulses into a series
of regular, high-frequency, and synchronized pulses (Figures
S2C–S2E). With increasing amount of damage, more cells
show p53 pulses with a detectable frequency, and the pulsatile
dynamics persist for longer (Figures S2F and S2G).
Spontaneous p53 Pulses Depend on Proliferation
and the ATM/DNA-PK Pathway
We next asked whether p53’s spontaneous pulses in non-
stressed conditions result from random activation of this path-
way or are linked to specific internal processes within the cell
such as cell-cycle progression. To answer this question, we
synchronized cells in silico by aligning individual trajectories to
the time of consecutive cell divisions and normalizing them to
the length of the cell cycle (Figures S3A and S3B) (Sigal et al.,
2006). Using flow cytometry, we were able to map the corre-
sponding cell-cycle phases to the synchronized trajectories
(Figures S3C–S3E) (Toettcher et al., 2008). We found that most
proliferating cells (>90%) induce a p53 pulse during one cell
cycle (Figure 3A) and that the pulses are correlated with specific
phases of the cell cycle: the distribution of the first p53 pulse
peaked during G1, at 20% of the cell cycle after mitosis
(Figure 3B); the occurrence of the second pulse wasmore widely
distributed around the boundary between the S and G2 phases
(Figure 3C).
To further determine whether there is a causal relationship
between cell-cycle progression and p53 pulses, we arrested
cells in G2 phase using the Cdk inhibitor RO3306 (Vassilev
et al., 2006) and measured p53 dynamics by time-lapse micros-
copy. Prior to drug addition, we detected spontaneous p53
pulses as before. However, after the Cdk inhibitor was added,
cells showed only residual pulses while progressing through S
into G2 phase, and stopped pulsing once the arrest was estab-
lished (Figure 3D and Figures S3F and S3G). This led to a strong
reduction in the mean number of p53 pulses compared to freely
cycling cells (Figure 3E), suggesting that cell-cycle progression
is causally related to spontaneous p53 pulses.
How might normal progression through the cell cycle activate
the p53 pathway? Proliferating cells are constantly confronted
with various forms of stress. The observation that cell-cycle
events associated with intrinsic DNA damage (e.g., mitosis and
replication) (Dart et al., 2004; Ichijima et al., 2005; Su, 2006;
Tanaka et al., 2006) increase the probability of a p53 pulse
suggests that p53 induction may be mediated by damage-acti-
vated regulators. To test this hypothesis, we inhibited different
kinases upstream of p53 (Figure 1A) (Bode and Dong, 2004)
and followed p53 dynamics in individual cells in nonstressed
conditions (Figure 3F). Inhibition of the stress kinase JNK or
the kinases ATR and Chk1, which participate in the response
to single-stranded DNA, had little effect (Figure 3F). In contrast,
inhibition of the kinases that dominate the response to double-
strand breaks, such as ATM, DNA-PK, or Chk2, reduced theCell 142, 89–100, July 9, 2010 ª2010 Elsevier Inc. 91
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Figure 2. p53 Dynamics in Living Cells
(A and B) Time-lapse microscopy images of cells expressing p53-Venus after treatment with NCS (200 ng/ml, A) or in nonstressed conditions (B).
(C and D) Individual cells were tracked and the average fluorescence was measured. Normalized trajectories of p53-Venus levels are shown. The vertical dashed
line indicates the time of cell division.
(E–H) The trajectories were analyzed computationally to identify p53 pulses and measure their properties (see the Extended Experimental Procedures).
(E) The mean relative amplitudes of p53 pulses in nonstressed or damaged (200 ng/ml NCS) cells are shown (n > 80; error bars indicate the standard deviation
[SD]).
(F) Histogram of p53 pulse width measured as full width at half maximum.
(G) The fraction of cells showing no pulse, one or two pulses, or three or more pulses in a 24 hr period.
(H) Histograms showing the time of the first pulse maxima.
See also Figure S2.number of p53 pulses significantly (Figure 3F). Similarly, inhibi-
tion of these kinases in a noncancerous breast epithelial cell
line (MCF10A) led to a specific reduction of p53 levels as
measured by immunofluorescence (Figures 3G and 3H). Specif-
ically, the right-sided tail, representing cells with high p53 levels,
was lost. This suggests that the activity of DNA damage-acti-
vated kinases is required for inducing p53 pulses in nonstressed
conditions, both in cancerous and in untransformed cells. Most
likely, these kinases are activated by transient damage that
occurs during normal progression through the cell cycle.
p53 Pulses Result from an Excitable Mechanism
Next, we asked how a transient low input (such as intrinsic
damage during growth) could lead to p53 pulses similar to the
ones seen in cells after severe damage by NCS or irradiation
(IR), especially since ATM activity might be lower, or of shorter92 Cell 142, 89–100, July 9, 2010 ª2010 Elsevier Inc.duration, under these conditions. One possibility is that the
p53 network behaves as an excitable system where a transient
input is sufficient for full activation, similar to action potentials
in neurons (Hodgkin and Huxley, 1952). To test this hypothesis,
we induced DNA damage with NCS and inhibited the upstream
kinases that activate p53 at different times after damage, thereby
creating transient input signals. If the network behaves as an
excitable system, transient and sustained inputs are expected
to trigger a similar p53 pulse. The resulting trajectories show
that indeed p53 levels continue to increase after inhibition of
upstream kinases, leading to a full p53 pulse (Figure 4A). Addi-
tion of the inhibitor at early time points reduced the number of
cells showing a p53 pulse (Figure 4B). However, once a p53
response was initiated, the amplitude and width of the pulse
remained unchanged (Figures 4C and 4D). We obtained similar
results for p53 pulses in nonstressed conditions; all cells that
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Figure 3. p53 Induction in Nonstressed Conditions Correlates with the Cell Cycle and Depends on the Activity of Upstream Kinases
(A–C) Cells were imaged for 48 hr in nonstressed conditions and synchronized in silico (see the Extended Experimental Procedures). The cumulative distribution
function of the timing of the first pulse is shown in relation to cell-cycle progression (A). About 90% of the cells show at least one pulse during one cell cycle, with
most cells showing the first pulse during G1 phase (dashed line). The distributions of the timing of the first (B) and second (C) pulses are shown (n > 80).
(D and E) Cells were imaged either untreated or during G2 cell-cycle arrest induced by the Cdk1 inhibitor RO3306 (9 mM).
(D) Sample trajectory of normalized p53 levels before and after treatment (solid line, drug addition; dashed line, cell division).
(E) Average number of pulses are shown for proliferating and arrested cells (error bars indicate the standard error of the mean [SEM]).
(F) Upstream kinases were inhibited either by siRNA or small molecules and cells were imaged for 24 hr in nonstressed conditions. The mean number of p53
pulses was extracted from single-cell trajectories and normalized to the number of pulses in control cells. ‘‘Mix’’ indicates cells simultaneously treated with
ATM, DNA-PK, and Chk2 inhibitor (error bars indicate the SEM; ** indicates p values of < 0.01 in t test).
(G and H) Distribution of basal p53 (G) and Lamin A (H) in MCF10A cells untreated (solid line) or treated with a mix of ATM, DNA-PK and Chk2 inhibitors (dashed
line).
See also Figure S3.initiated a p53 pulse before addition of the inhibitor completed
a full pulse (Figure 4E). These results suggest that p53 pulses,
in both nonstressed conditions and in response to extrinsic
damage, are excitable and independent of the damage duration.
Such a mechanism fulfills the requirement for a highly sensitive
response since it ensures that the pathway is fully activated
even in response to low level transient damage.
Spontaneous p53 Pulses Are Filtered by a Network
of Posttranslational Modifications
In damaged cells, p53 leads to cell-cycle arrest or apoptosis
(Vogelstein et al., 2000). We did not observe cell death or arrest
in response to spontaneous p53 pulses in nonstressed condi-
tions (see for example Figures S3A and S3F), suggesting that
the corresponding target genes are not expressed. To take
a closer look at the function of spontaneous p53 pulses, we
measured the transcription of p21, a well-characterized p53
target gene involved in cell-cycle arrest (el-Deiry et al., 1993).
By expressing a destabilized version of the red fluorescent pro-
tein mCherry under the control of the p21 promoter (Figure 5A),
wewere able tomeasure p21 induction and p53 dynamics simul-
taneously in individual cells (Figures 5B and 5C). After DNA
damage, the p21 reporter was induced in about a third of the
cells (Figures 5D and 5F and Figure S4A). In contrast, the p21
reporter stayed at basal levels in nonstressed conditions, even
in cells showing multiple p53 pulses at a comparable level to
those in damaged cells (Figures 5E and 5G and Figure S4B).In agreement, measurements of both p53 and p21 proteins in
normal human epidermis using immunofluorescence revealed
that cells with high p53 levels did not have detectable levels of
p21 (Figures 5H–5H00 0).
The observation that spontaneous p53 pulses do not activate
p21 expression suggests that p53 is inactive as a transcriptional
activator in nonstressed conditions and that transient low
damage, like the one cells encounter during normal growth, is
insufficient to convert it to its active form. To test this hypothesis,
we generated transient input signals as explained above
(Figure 4) and followed p53 levels and p21 expression simulta-
neously in live cells. We found that transient input signals
(for 30 min after damage) excite a full p53 pulse but do not
allow p21 activation (Figure 6B and Figure S5A). If we allowed
the upstream signal to persist for longer (adding the inhibitor
60 min after damage), more cells showed p21 activation
(Figure 6C). These results suggest that in the absence of sus-
tained kinase activation, even full induction of total p53 protein
is insufficient for inducing target genes such as p21. Accordingly,
we found that induction of p53 with a zinc-inducible promoter,
which leads to high levels of p53 (about 1.5-fold higher than after
damage) did not result in p21 activation (Figures S5B–S5D),
further supporting that p53 levels are uncoupled from its tran-
scriptional activity.
Uncoupling of p53’s accumulation and transcriptional activity
could be achieved by the numerous posttranslational modifica-
tion on p53 (Bode and Dong, 2004; Kruse and Gu, 2009).Cell 142, 89–100, July 9, 2010 ª2010 Elsevier Inc. 93
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Figure 4. p53 Pulses Are Triggered by an Excitable Mechanism
(A–D) Cells expressing p53-Venus were damaged with 400ng/ml NCS and
imaged for 6 hr. Wortmannin (wm, 100 mM) was added at the indicated time
points and subsequently refreshed every hour. p53 dynamics were analyzed
in single-cell trajectories (n > 100).
(A) A sample trajectory is shown where wortmannin was added after 30 min
(vertical line).
(B) Treatment with wortmannin reduced the number of cells showing a p53
pulse.
(C and D) The amplitude of p53 pulses (C) and their duration (D) were
unchanged (error bars indicate the SD).
(E) Cells were imaged in nonstressed conditions for a total of 8 hr; after 3 hr,
100 mM wortmannin was added. Trajectories of normalized p53 levels from
two cells are shown (vertical line, addition of wortmannin). Cells that initiated
a p53 pulse before inhibitor addition continued to show a full pulse.Specifically, modifications in the C-terminal domain have been
suggested to control p53’s activity as a transcription factor;
acetylation at residues K373 and K382 by the transcriptional
co-activator CBP/p300 (Figure 6A) (Barlev et al., 2001; Li et al.,
2007; Tang et al., 2008) were shown to increase p53’s transcrip-
tional activity, whereas methylation of these lysines can play an
inhibitory role. Methylation of K382 by the methyltransferase
SET8, for instance, has been reported to keep p53 in a transcrip-
tionally inactive state (Shi et al., 2007).
To determine whether posttranslational modifications play
a role in uncoupling p53 accumulation from its transcriptional
activity, we analyzed the state of C-terminal lysines in response
to sustained and transient activation using antibodies against
acetylated K373 and K382 as readout for p53’s acetylation in94 Cell 142, 89–100, July 9, 2010 ª2010 Elsevier Inc.general. Sustained damage by NCS led to acetylation of both
residues (Figure 6D). In contrast, almost no acetylation was de-
tected in response to a transient input (when the inhibitor was
added 30 min after damage), although total p53 levels continued
to increase (Figure 6D).
To directly analyze acetylation of p53 in nonstressed condi-
tions, we synchronized cells using the Cdk1 inhibitor RO3306
(Vassilev, 2006) and determined the modification state of
p53 during its accumulation in G1 phase. No acetylation was
detected in p53’s spontaneous accumulation while cells reenter
the cell cycle, in contrast to its accumulation in response to sus-
tained damage (Figure S5E). This lack of acetylation correlated
with no induction of p21messenger RNA (mRNA) in nonstressed
conditions (Figure S5E). These results show that although
accumulation of p53 is excitable and independent of the input
duration, the shift in its acetylation state requires continuous
input from the upstream kinases post damage (Figure S5F).
We next sought to change the acetylation state of p53 in non-
stressed conditions and test the effect on its ability to activate
p21. We used the deacetylase inhibitor JW1521, which, in pop-
ulation measurements, induced the accumulation of acetylated
p53 (Figure 6E) (Roy et al., 2005). We found both in western
blot (Figure 6E) (Roy and Tenniswood, 2007) and in individual
living cells that this change in modification state led to activation
of p21 expression in the absence of extrinsic damage in a p53
dependent manner (Figure 6F and Figure S5G). This indicates
that changing the acetylation pattern of p53 during its sponta-
neous pulses increases its transcriptional activity and allows
induction of p21.
As deacetylase inhibitors might affect various pathways in the
cell, we next aimed to alter p53 modifications in a more specific
way. We chose to inactivate the methyltransferase SET8, which
has been shown to mediate the inhibitory methylation of p53 at
K382 (Shi et al., 2007). We established stable SET8 short hairpin
RNA (shRNA)-expressing cell lines and followed p53 dynamics
and p21 induction (Figures 6G–6I and Figures S5H–S5K). We
found that p21 induction was about 2-fold more frequent in
SET8 knockdown cells compared to control cells (Figure 6I
and Figure S5J). We suspect that SET8 shRNA did not lead to
p21 induction in all cells as a result of an incomplete knockdown
of SET8 and the presence of other compensatory inhibitory
modifications, for example, methylation at K370 by the methyl-
transferase Smyd2 (Huang et al., 2006). Interestingly, the same
number of cells induced p21 after extrinsic damage in the
SET8 shRNA and control cell lines (Figure S5L), indicating that
the inhibitory methylation is overridden by the strong damage
stimulus.
Taken together, our results show that the interplay between
inhibitory and activating modification at p53’s C-terminal
domain provides a filtering mechanism that distinguishes p53
pulses after sustained damage, caused by irradiation or drugs,
from spontaneous p53 pulses caused by transient and low-
level damage during normal proliferation. In both cases p53 is
excited and shows a full pulse. However upregulation of p53’s
transcriptional activity is not excitable; sustained damage is
required to change p53’s modification profile and evoke the
corresponding cellular responses, for example, cell-cycle arrest
or apoptosis.
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Figure 5. p53 Pulses in Nonstressed Conditions Do Not Activate p21 Expression
(A) Schematic drawing of the p53 and p21 reporter constructs.
(B and C) Time-lapse images of cells expressing the p53 and p21 reporters after damage (400 ng/ml NCS, B) or in nonstressed conditions (C).
(D and E) Single-cell trajectories from the cells depicted above showing p53 dynamics (solid line) and the p21 reporter (dashed line).
(F and G) Integrated fluorescence intensity of p53-Venus versus the fold induction of the p21 reporter for damaged (F) and nonstressed (G) cells. Integrated p53
intensities were calculated from trajectories prior to normalization. Dashed line indicates median of non-stressed cells + 1.5 SD as a guideline.
(H–H00 0) p21 and p53 levels in normal human tissues. Sections of formaldehyde-fixed paraffin-embedded normal human epidermis were stained with p53 (H) and
p21 (H0) antibodies and DAPI (H00). An overlay of the p21 (red) and p53 (green) channels is shown in (H00 0). Arrows indicate cells with high levels of p53.
See also Figure S4.DISCUSSION
One major objective of signaling pathways is to cope with, and
filter, noisy environments, which often produce transient low-
level inputs. This goal is especially challenging when dealing
with dangerous inputs such as DNA damage. Cells must ensure
they react appropriately in response to damage but keep
growing in response to transient spontaneous insults. How is
this delicate balance achieved? The results presented in this
study suggest that the p53 pathway meets these requirements
by combining a highly sensitive activation mechanism with anintricate filtering mechanism. Transient intrinsic damage during
normal growth is detected by damage sensors, including the
kinases ATM and DNA-PK. This triggers a pulse of p53 accumu-
lation (Figure 7A). However, p53’s ability to arrest the cell cycle
and activate its target genes such as p21 depends on specific
posttranslational modifications, which occur only in response
to severe extrinsic damage (Figure 7A).
The level of spontaneous damage during growth ismuch lower
than the damage in irradiated cells. However, our results show
that p53 pulses in nonstressed conditions are as strong as the
pulses in irradiated cells. How is this possible? Here, we provideCell 142, 89–100, July 9, 2010 ª2010 Elsevier Inc. 95
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Figure 6. Posttranslational Modifications Control p53 Activity in Nonstressed Cells
(A) Schematic drawing of the p53 protein domains including selected posttranslational modifications in the N- and C-terminal domains. The modified residues
and the responsible enzymes are indicated.
(B and C) Cells expressing p53-Venus and the p21 reporter were damaged with 400 ng/ml NCS and imaged for 6 hr. Wortmannin (100 mM) was added at the
indicated time points and subsequently refreshed every hour. p53 dynamics were analyzed in single-cell trajectories (n > 100).
(B) A sample trajectory is shown, where wortmannin was added after 30 min (vertical line). Although a full p53 pulse is induced (solid line), no activation of p21 can
be detected (dashed line).
(C) p21 induction in cells inducing a full p53 pulse. The analyzed cells showed the same mean p53 amplitude (see Figure S5A). When wortmannin was added
30 min after damage, no induction of p21 was detected. Only if the upstream kinases were active for longer, more cells induced p21 expression.
(D) MCF7 cells were damaged with g-IR (10 Gy) and harvested at the indicated time points. After 30 min, wortmannin (100 mM) was added to one half of the
samples and subsequently refreshed every hour. Western blot analysis showed that sustained kinase input led to acetylation of p53. However, addition of wort-
mannin prevented the change in the C-terminal modifications, even though total p53 level continued to increase. Since not all cells have excited a p53 pulse by
30 min (Figure 4B), the peak levels of p53 are lower in this condition.
(E) MCF7 and MCF7+p53shRNA cells were treated with the histone deacetylase (HDAC) inhibitor JW1521 and analyzed by western blot.
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Figure 7. p53’s Dynamics and Regulation in Response to Sustained and Transient Damage
(A) A highly sensitive mechanism activates p53 in response to low transient DNA damage during normal growth and in response to severe damage caused by
irradiation or drugs. In both cases, p53 shows pulses of similar amplitude and duration. Transient low damage is insufficient to relief the suppression on p53
activity, resulting in no induction of p21 or cell-cycle arrest. Sustained severe damage changes the modification state of p53 to an active form, leading to p21
accumulation and cell-cycle arrest.
(B) A persistence detector based on a feed-forward motif. An excitable mechanism leads to accumulation of p53 protein independent of the duration of the
upstream signal. A second mechanism, which depends on sustained signaling, is required to convert p53 to its active form, allowing expression of its target
genes. Transient damage excites p53 but is insufficient to engage the second arm of the response. Therefore, the accumulated p53 protein remains inactive.evidence that this dynamical behavior results from an excitable
system. Perturbation of the network over a certain threshold
leads to full p53 accumulation. As a result, transient low damage
leads to a pulse with amplitude and duration similar to those in
response to sustained severe damage (Figure 7A). The level of
DNA damage therefore does not affect the shape of p53 pulses
but only their number in each cell. In addition, such an excitable
behavior contributes to, and fits with, the requirements for
a sensitive damage-sensing mechanism in response to DSBs,
which are among the most dangerous types of DNA damage.
While excitability ensures that p53 reacts to low levels of
damage, it creates the need to filter pulses that result from low
intrinsic damage (‘‘false alarms’’), which can be fixed promptly
and do not justify cell-cycle arrest. One way to achieve this
goal is to suppress p53’s activity during the response to transient
low damage and to allow its activation only after severe extrinsic
damage (Figure 7A). Our results suggest that such a switching
mechanism may be implemented through C-terminal modifica-
tions of p53. Two lines of evidence support the idea of interplay
between inhibitory and activating modifications: First, increasing
the level of activating acetylation led to p53-mediated expres-
sion of the target gene p21 even in the absence of damage.(F) Integrated fluorescence intensity of p53-Venus versus the fold induction of the
treated cells show induction of the reporter (dashed line =median of control + 1.5 S
detected in response to JW1521 treatment.
(G–I) SET8 knockdown leads to induction of p21 in nonstressed conditions.
(G) SET8mRNA levels weremeasured byRT-qPCR in cells stably expressing spec
and then to the level in cells without shRNA. (error bars indicate the SD).
(H) Single-cell trajectory of a cell in nonstressed conditions after SET8 knockdow
(I) The fraction of cells inducing the p21 reporter above a threshold (median of co
indicate the SD).
See also Figure S5.Second, reducing the activity of the inhibitory methyltransferase
SET8 had a similar effect. Interestingly, it has been shown that
upon DNA damage, the activity of the inhibitory enzymes SET8
and Smyd2 is reduced, while activating factors like SET7/9 or
CPB/p300 show increased activity (Huang et al., 2006; Ivanov
et al., 2007; Li et al., 2007; Shi et al., 2007). DNA damage
signaling therefore seems to play a dual role in regulating p53
levels and activity. Transient DNA damage triggers p53 accumu-
lation. However, sustained damage signaling is necessary to
change the p53 modification state from inhibitory to active. In
this scenario, damage-activated kinases such as ATM would
(1) directly modify p53 to increase its stability and (2) induce
p53’s acetylation/demethylation indirectly via regulation of inter-
mediate enzymes, forming a coherent feed-forward network
motif (Figure 7B). Similarly, Alon and colleagues have previously
shown that in bacterial transcriptional networks coherent feed
forward loops can act as persistence detectors that filter brief
spurious signals in noisy environments (Alon, 2007; Mangan
et al., 2003). In the p53 network, accumulation of p53 soon
becomes independent of kinase input through an excitable
mechanism (Figure 7B). In contrast, the change of the modifica-
tion pattern happens on a slower time scale and requiresp21 reporter for control cells and cells treated with JW1521. About a third of the
D). In cells stably infected with a p53shRNA retrovirus, no induction of p21 was
ific or control shRNA. SET8 levels were normalized first to GAPDHmRNA levels
n (p53 reporter, solid line; p21 reporter, dashed line).
ntrol + 1.5 SD) are shown (mean of three independent experiments; error bars
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sustained upstream signaling (Figure 7B). A plausible explana-
tion for the delay in acetylation is the slow accumulation and
nuclear transport of cofactors like Strap that are necessary for
p300/CBP-mediated modification of p53 (Adams et al., 2008;
Demonacos et al., 2004).
In the present study, we focus on the interplay of methylation
and acetylation in the C-terminal domain. However, it is conceiv-
able that additional modifications play a role in regulating p53
activity. The need for intricate processing beyond p53 stabiliza-
tion may indeed be one explanation for the overwhelming
complexity of p53 modifications. This also highlights the impor-
tance of studying the behavior of signaling pathways not only
after external stimulation, but also in response to basal internal
processes during normal growth. If the p53 network is viewed
only in light of induced DNA damage, its architecture might
seem overly complicated. However if one considers its frequent
activation in proliferating cells, the need for further complexity
becomes obvious.
Although our results indicate that p53 pulses in nonstressed
conditions do not lead to expression of canonical target genes
involved in cell-cycle arrest, it is possible that the suggested
filtering mechanisms are gene specific, allowing the expression
of other target genes by spontaneous p53 pulses (Riley et al.,
2008). For example, recent studies identified genes, including
Sestrin 1 and Glutathione Peroxidase 1, with expression levels
that are influenced by p53 knockdown in normally proliferating
cells (Godar et al., 2008; Sablina et al., 2005). In addition, the
downregulation of p53 at the end of a pulse indicates that
the Mdm2 negative feedback is active. It has been previously
reported that Mdm2 levels change dynamically even in non-
stressed conditions (Geva-Zatorsky et al., 2006). Accordingly,
we see an increase in Mdm2 protein levels after p53 accumula-
tion in G1 phase and in response to induction of p53 with an
inducible promoter in nonstressed conditions (data not shown),
in agreement with studies indicating that the architecture of the
Mdm2 promoter allows its activation independent of C-terminal
p53 acetylation (Kaku et al., 2001; Tang et al., 2008).
Our study provides an example of how analysis of the basal
dynamics of a signaling pathway can provide new insights into
the system’s behavior. The p53 network might be just one
example of a signaling network showing complex dynamics in
the absence of extrinsic stimuli. Our approach of looking at basal
dynamics in individual cells can now be extended to other
signaling pathways and especially to other pulsatile or oscillatory
transcription factors, such as NFkB (Nelson et al., 2004). It will be
important to determine the basal dynamics of these signaling
pathways; whether dynamic changes also occur in the absence
of extrinsic input, and what this can teach us about information
processing in response to extrinsic inputs.
EXPERIMENTAL PROCEDURES
Cell Culture
MCF7 cells were grown in RPMI + 10% fetal bovine serum (FBS) supple-
mented with selective antibiotics (400 mg/ml G418, 5 mg/ml blasticidin, and
0.5 mg/ml puromycin) when needed. HCT116 cells were grown in McCoy’s +
10% FBS and RPE-hTERT in Dulbecco’s modified Eagle’s medium (DMEM)/
F12 + 10% FBS. MCF10A cells were cultured in DMEM/F12 + 5% horse serum
with 20 ng/ml epidermal growth factor, 0.5 mg/ml hydroxycortisone, 100 ng/ml98 Cell 142, 89–100, July 9, 2010 ª2010 Elsevier Inc.cholera toxin, and 10 mg/ml insulin. All media contained penicillin, strepto-
mycin, and fungizone. The MCF7 p53 reporter cell line has been previously
described (Batchelor et al., 2008). The dual p53/p21-promoter reporter cell
line was created with a 2.4 kb fragment of the p21 promoter (el-Deiry et al.,
1993) and the SET8-shRNA cell line by cloning of specific oligonucleotides
into pRetroSuper.puro (Brummelkamp et al., 2002a). See the Extended Exper-
imental Procedures for details. VSV-G pseudotyped retroviral particles ex-
pressing SET8 shRNA or p53 shRNA (Brummelkamp et al., 2002b) were
produced in 293T cells.
Antibodies and Reagents
We used antibodies against p53 (DO1 and FL-393, Santa Cruz), acK373-p53
and acK382-p53 (Abcam), p21 (Calbiochem), Actin (Sigma), and Lamin A/C
(T. Mitchison). Neocarzinostatin was obtained from the National Cancer Insti-
tute or Sigma; the ATM inhibitor KU55933 (used at 5 mM), the Chk1 inhibitor
SB218078, Chk2 inhibitor II, and JNK inhibitor II (all used at 10 mM) from
Calbiochem; the DNA-PK inhibitor NU7026 (used at 10 mM) from Sigma; the
Cdk1 inhibitor RO3306 (used at 9 mM) and wortmannin (used at 100 mM)
from Alexis Biochemicals; and JW1521 from Errant Gene Therapeutics (used
at 7.5–10mM). DharmaFect 1 and SMARTpool small interfering RNA (siRNA)
from Dharmacon were used for ATM and ATR knockdowns.
Western Blot Analysis
We harvested cells, obtained protein extract by lysis in the presence of
protease and deacteylase inhibitors, and quantified total protein amount
with the BCA assay (Pierce). Equal protein amounts were separated by elec-
trophoreses on 4%–12% Bis-Tris gradient gels (Invitrogen) and transferred
to PVDF membranes by electroblotting. We blocked membranes with 5%
nonfat dried milk, incubated them overnight with primary antibody, washed
them, incubated them with secondary antibody coupled to peroxidase, and
detected protein levels with chemoluminiscence (ECL plus, Amersham) after
additional washing steps.
Live-Cell Microscopy
For live-cell time-lapse microscopy, cells were plated in RPMI without phenol
red and riboflavin supplemented with 10% FBS in poly-D-lysine coated glass-
bottom plates (MatTek Coporation). Cells were imaged on a Nikon Eclipse
TE-2000 inverted microscope with a 403 plan apo objective (NA 0.95) with
a Hammamatsu Orca ER camera. See the Extended Experimental Procedures
for filter sets used. The microscope was enclosed with an environmental
chamber controlling temperature, atmosphere (5% CO2), and humidity.
Images were acquired every 15 or 20 min for 6–48 hr. Image acquisition was
controlled by MetaMorph Software (Molecular Devices); image analysis was
done with ImageJ (NIH) and Matlab (MathWorks).
Immunofluorescence
Cells were grown on coverslips coated with poly-L-lysine and fixed with 4%
paraformaldehyde. Cells were permeabilized in PBS/0.2% Triton, blocked
with 10% goat serum, incubated with primary antibody, washed, and incu-
bated with secondary antibody coupled to either Alexa488 or Alexa647. After
washing, cells were stained with Hoechst and embedded in Prolong Antifade
(Invitrogen). Images were acquired with a 203 plan apo objective (NA 0.75)
with the appropriate filter sets. Automated segmentation was performed in
Matlab (MathWorks) with algorithms from CellProfiler (Carpenter et al.,
2006). Twenty to sixty thousand cells were measured per condition.
Thin sections from paraffin-fixed normal human tissues (Imgenex) were
heated to 62C for 1 hr, washed 53 4min in xylene, 23 3min in 100%ethanol,
23 3min in 95% ethanol, 23 3min in 75% ethanol, and 13 5min in tap water.
For antigene recovery, slides were microwaved 3 3 5 min in 10 mM citrate
buffer (pH 6.0) and subsequently immersed in cold PBS. Staining was
continued as described above.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and one movie and can be found with this article online at doi:
10.1016/j.cell.2010.05.031.
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